Newbury Pharmaceuticals AB (publ) reported earnings results for the third quarter and nine months ended May 31, 2023. For the third quarter, the company reported sales was SEK 5.68 million compared to SEK 0.644 million a year ago. Net loss was SEK 4.09 million compared to SEK 3.37 million a year ago.
For the nine months, sales was SEK 7.44 million compared to SEK 0.946 million a year ago. Net loss was SEK 14.68 million compared to SEK 10.77 million a year ago.